HLS Therapeutics Inc
TSX:HLS

Watchlist Manager
HLS Therapeutics Inc Logo
HLS Therapeutics Inc
TSX:HLS
Watchlist
Price: 5.67 CAD 1.25% Market Closed
Market Cap: 177.6m CAD

HLS Therapeutics Inc
Investor Relations

HLS Therapeutics, Inc. operates as a pharmaceutical company. The company is headquartered in Etobicoke, Ontario and currently employs 92 full-time employees. The firm is focused on developing clinically differentiated pharmaceutical products in the specialty central nervous system (CNS) and cardiovascular (CV) markets. Its products include Vascepa, Trinomia, Clozaril, CSAN Pronto, PERSERIS and MyCare Psychiatry/MyCare Insite. Its lead product, Clozaril, is an atypical antipsychotic indicated in the management of symptoms of treatment-resistant schizophrenia for the Canadian and United States markets. CSAN Pronto is a capillary point-of-care medical device designed to enhance and simplify the mandatory safety blood monitoring process for patients that are prescribed Clozaril. Vascepa capsules reduce the risk of cardiovascular events, such as cardiovascular death, non-fatal myocardial infarction, non-fatal stroke, coronary revascularization, or hospitalization for unstable angina in statin-treated patients with elevated triglycerides.

Show more
Loading
HLS
S&P TSX Composite Index (Canada)
1Y 3Y 5Y 10Y 15Y 20Y
Last Earnings Call
Fiscal Period
Q2 2025
Call Date
Aug 14, 2025
Q2 2025 Earnings Call
No Analysis Available

This earnings call has not been analyzed yet.

If you’d like us to analyze this earnings call, click the "Request Earnings Call Analysis" button below.

Request Earnings Call Analysis
Earnings Call Recording
Open Transcript
Other Earnings Calls

Management

Mr. Craig Stuart Millian M.B.A.
CEO & Director
No Bio Available
Mr. John Hanna CPA, CGA, M.B.A.
CFO & Non-Independent Director
No Bio Available
Dr. Jason A. Gross Pharm.D.
Vice President of Scientific Affairs
No Bio Available
Mr. Ryan C. Lennox B.A., J.D.
Senior VP of Legal, HR & Compliance and Corporate Secretary
No Bio Available
Mr. Brian T. Walsh
Chief Commercial Officer
No Bio Available
Dave Mason
Investor Relations Officer
No Bio Available
Mr. David Spence
VP & Corporate Controller
No Bio Available

Contacts

Address
ONTARIO
Etobicoke
10 Carlson Crt Suite 410
Contacts
+16474959000.0
www.hlstherapeutics.com
sparklesyt

See Also

Summary
HLS intrinsic value, competitors valuation, and company profile.
DCF Valuation
HLS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
HLS stock valuation using valuation multiples.
Wall Street Estimates
HLS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
HLS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Back to Top
ALPHA SPREAD
Follow us
Join more than 283,100+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.